Company Filing History:
2 out of 3 
1 out of 9 Years Active: 2022-2025
Title: Michael Prakesch: Innovator in Cancer Research
Introduction
Michael Prakesch is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer research through his innovative work and patented inventions. With a total of three patents to his name, Prakesch is recognized for his dedication to advancing medical science.
Latest Patents
Among his latest patents, Prakesch has developed compounds such as substituted carboxamides, which serve as inhibitors of WDR5 protein-protein binding. This application is directed to compounds of Formula I. Additionally, he has worked on substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction. This patent relates to compounds of Formula I or pharmaceutically acceptable salts, solvates, and/or prodrugs thereof, which are aimed at treating diseases, disorders, or conditions that can be addressed by inhibiting interactions with BCL6 BTB, including cancer.
Career Highlights
Throughout his career, Prakesch has been associated with prominent organizations such as Propellon Therapeutics Inc. and the Ontario Institute for Cancer Research. His work in these institutions has allowed him to focus on groundbreaking research and development in the field of oncology.
Collaborations
Prakesch has collaborated with several professionals in his field, including Rima Al-Awar and Methvin Benjamin Isaac. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.
Conclusion
Michael Prakesch stands out as an influential inventor in the realm of cancer research, with a strong portfolio of patents that reflect his commitment to innovation. His work continues to pave the way for new therapeutic approaches in the fight against cancer.